John Mack is right.

John Mack of Pharma Blogosphere fame is pointing out that I didn't immediately follow the pack yesterday and jump on Pfizer Inc.'s latest debacle.  And he's right. When possible, the BrandweekNRX philosophy is to try to find those stories you can't read anywhere else.

So I allowed my exclusive post "New drug therapy: Smell of breasts drive women wild" remain on top for an extended period.

John speculates that "Rost scores technorati points for keeping the breast post at the top of his blog list for several days while the drug industry burns and bombs all around him!"

I guess there is no easy way to say this: I'm a sucker for readership numbers, and the smell of breasts clearly beats a burning bong:

Comments

[John Mack]

No surprise here! Like every other heterosexual male, I enjoy a good boob story now and then, especially if accompanied by graphics.

I wonder, however, how many of Brandweek's regular subscribers are female and what they might think of all this? Sex sells, I guess. Even female advertising execs probably buy into that maxim.